41 studies found for:    "Bacterial Infections" | Mexico
Show Display Options
Rank Status Study
1 Completed
Has Results
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
Condition: Bacterial Infections
Interventions: Drug: ceftaroline;   Drug: vancomycin plus aztreonam;   Drug: Placebo
2 Completed
Has Results
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
Condition: Bacterial Infections
Interventions: Drug: IV Vancomycin plus IV Aztreonam;   Drug: Ceftaroline
3 Completed BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis
Condition: Bacterial Infections
Interventions: Drug: Ciprofloxacin single dose;   Drug: Ciprofloxacin triple dose
4 Completed
Has Results
Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.
Conditions: Bacterial Infections;   Diabetic Foot;   Osteomyelitis
Interventions: Drug: Tigecycline;   Drug: Ertapenem
5 Completed TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Condition: Skin and Subcutaneous Tissue Bacterial Infections
Interventions: Drug: TR-701 FA for 6 days followed by 4 days of placebo;   Drug: Linezolid for 10 days of treatment
6 Completed
Has Results
Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age
Conditions: Bacterial Infections;   Intra-Abdominal Infection;   Pneumonia, Bacterial;   Skin Diseases, Bacterial;   Skin Diseases, Infectious
Intervention: Drug: Tygacil
7 Completed
Has Results
A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection
Condition: Musculoskeletal Diseases
Intervention: Drug: No intervention
8 Completed
Has Results
Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Poliomyelitis
Interventions: Biological: DTaP-IPV-HB-PRP~T vaccine;   Biological: DTaP-HBV-IPV vaccine
9 Completed
Has Results
Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Poliomyelitis;   Haemophilus Influenzae Type B Infection
Interventions: Biological: DTaP-IPV-Hep B-PRP~T vaccine (Batch 1);   Biological: DTaP-IPV-Hep B-PRP~T vaccine (Batch 2);   Biological: DTaP-IPV-Hep B-PRP~T vaccine (Batch 3);   Biological: Infanrix Hexa™
10 Completed Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents
Conditions: Diphtheria;   Tetanus;   Acellular Pertussis
Interventions: Biological: Boostrix TM (new syringe presentation);   Biological: Boostrix TM (previous syringe presentation)
11 Completed
Has Results
Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.
Conditions: Diphtheria;   Tetanus;   Pertussis;   Haemophilus Influenzae Type b;   Hepatitis B
Interventions: Biological: DTaP-IPV-HB-PRP~T;   Biological: Tritanrix-HepB/Hib
12 Active, not recruiting Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers
Conditions: Tetanus;   Diphtheria;   Haemophilus Influenzae Type b;   Whole Cell Pertussis;   Hepatitis B
Interventions: Biological: Meningococcal vaccine GSK 134612;   Biological: SynflorixTM;   Biological: Infanrix-IPV/HiberixTM
13 Recruiting Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection
Condition: Clostridium Difficile Infection
Interventions: Biological: C. difficile Toxoid Vaccine;   Biological: Placebo: 0.9% normal saline
14 Recruiting Safety and Immunogenicity of Novartis Meningococcal Group B Vaccine When Administered Concomitantly With Novartis MenACWY Conjugate Vaccine to Healthy Infants
Condition: Meningococcal Disease
Interventions: Biological: rMenB+OMV and MenACWY;   Biological: rMenB+OMV;   Biological: MenACWY
15 Recruiting Implementation of an Efficacious Intervention for High Risk Women in Mexico
Conditions: HIV;   Syphilis;   Gonorrhea;   Chlamydia
Interventions: Behavioral: Mujer Segura;   Behavioral: CENSIDA counseling program
16 Completed
Has Results
13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico
Condition: Pneumococcal Infections
Intervention: Biological: vaccine-13vPnC
17 Completed
Has Results
Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
Condition: Methicillin Resistant Staphylococcus Aureus (MRSA)
Interventions: Drug: linezolid (Zyvox);   Drug: vancomycin
18 Completed Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™
Condition: Infections, Streptococcal
Interventions: Biological: Synflorix™ (3-Dose);   Biological: Synflorix™ (2-Dose);   Biological: Synflorix™ (Single Dose);   Biological: Prevenar 13 ™ (Single Dose);   Biological: Prevenar 13 ™ (2-Dose)
19 Completed
Has Results
Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
Conditions: Skin/Soft Tissue Infections;   Methicillin Resistant Staphylococcus Aureus (MRSA)
Interventions: Drug: linezolid;   Drug: vancomycin
20 Unknown  Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment
Conditions: HIV;   AIDS;   Tuberculosis
Interventions: Drug: Simultaneous ARV and antiMTB;   Drug: Deferred RV and antiMTB treatment

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years